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The type 2 diabetes-specific dementia risk
score (DSDRS) is associated with frailty,
cognitive and functional status amongst
Mexican community-dwelling older adults
Omar Yaxmehen Bello-Chavolla1,2,3* , Carlos Alberto Aguilar-Salinas2,4,5 and José Alberto Avila-Funes6,7
Abstract
Background: The type 2 diabetes (T2D) specific dementia-risk score (DSDRS) was developed to evaluate dementia
risk in older adults with T2D. T2D-related factors have been shown increase the risk of age-related conditions,
which might also increase dementia risk. Here, we investigate the associations of DSDRS with frailty, disability,
quality of life (QoL) and cognition in community-dwelling older adults with T2D.
Methods: We included 257 community-dwelling older adults with T2D to evaluate the association between DSDRS
and Mini-mental state examination (MMSE), Isaac’s set-test (IST), clock drawing test (CDT), quality of life (SF-36), risk
of malnutrition (Mini-Nutritional Assessment or MNA), as well as frailty, Katz’ and Lawton-Brody scores. We also
assessed the phenotype and correlates of high-estimated dementia risk by assessing individuals with DSDRS >75th
age-specific percentiles.
Results: Mean age of participants was 78.0 ± 6.2 years. DSDRS showed a significant correlation with MMSE test, IST,
CDT, SF-36, MNA, Lawton-Brody and Katz scores, and an increasing number of frailty components. DSDRS was
higher among frail, pre-frail, and subjects with limited ADL and IADL (p < 0.001). Participants with DSDRS >75th age-
specific percentiles had lower education, MMSE, IST, SF-36, MNA, Katz, Lawton-Brody, and higher frailty scores. High-
estimated 10-year dementia risk was associated with ADL and IADL disability, frailty and risk of malnutrition. When
assessing individual components of DSDRS, T2D-related microvascular complications were associated to all
outcome measures.
Conclusion: The DSDRS is associated with frailty, disability, malnutrition and lower cognitive performance. These
findings support that T2D-related factors have significant burden on functional status, QoL, disability and dementia
risk.
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Background
Type 2 diabetes mellitus (T2D) is a main cause of morbidity
and mortality in the Western World; the highest preva-
lence of T2D cases occurs in individuals over 60 years
in whom it contributes to premature mortality and
disability [1]. Consistent epidemiological evidence has
shown an increased risk of incident all-cause, vascular
and Alzheimer’s disease dementia in individuals with
T2D [2, 3]. Screening of dementia risk has gained
interest recently, particularly upon identification of
modifiable risk factors for dementia to design strat-
egies aimed at delaying or preventing disease onset
[4]. Risk stratification in individuals with T2D might
be particularly useful, since dementia in individuals
with T2D has an earlier onset, thus having significant
impact on function and cognition in older adults [5].
Recently, thediabetes-specificdementia risk score (DSDRS)
wasdeveloped toevaluatedementia risk inAmericanolder in-
dividuals with T2D. DSDRS predicts of all-cause dementia by
evaluatingdiabetes-specificriskfactors includingmicrovascu-
larcomplications,hyperglycemicandhypoglycemiccrisesand
diabetic foot along with traditional risk factors for dementia
such as age, schooling, cardiovascular disease, and depression
[6]. Accumulated risk attributable to T2D-related factors has
also been independently associated to age-related conditions
including frailty, disability and cognitive impairment [7]. In
addition,disability, frailtyandcognitiveimpairmentareassoci-
ated to riskofmalnutrition, late-life depressionand functional
impairment, leading to increase dependence and decreasing
qualityof lifebesidesincreasingdementiarisk[8,9].Therefore,
theclinical utilityof screening individualsusingDSDRSmight
beapproachedwiththeaimofdesigningspecifictreatmentreg-
imens to improve quality of life (QoL) and functional status in
at-riskolderadults[10].Furthermore,sinceimpairedcognition
and dementia have significant negative impacts on T2D self-
care,closerattentionmightbegivento individuals identifiedat
higherbaselinerisk[11].
Despite the practicality of the score, the functional
and cognitive phenotype identified by the score has
not been described beyond clinical features related to
T2D. We hypothesized that individuals with higher
DSDRS would have functional and cognitive impair-
ment, which are likely to also impact T2D self-care
and QoL. Therefore, the main objective of the present
study was to determine the associations of the DSDR
S with frailty, disability, and cognitive measures aim-
ing to identify the cross-sectional phenotype which
relates it to conditions linked to high-dementia risk
in subjects with T2D.
Methods
Study population
We performed a cross-sectional study of 257 older
adults aged ≥70 years who participated in the Coyoacán
Cohort, an observational study conducted in the Coyoa-
cán borough located in Southern Mexico City conducted
between 2008 and 2009. Complete methodological de-
tails for the design and protocols of this study have been
published elsewhere, and questionnaire materials were
similar for the full cohort [7, 12]. Briefly, recruited
participants were non-institutionalized older adults
with residence in Coyoacán who were registered at
the comprehensive “Food Support, Medical Care and
Free Drugs Program” (FMDP) government program.
All participants underwent face-to-face interviews to
collect self-reported socio-demographic and health
data and a comprehensive geriatric assessment which
included physical performance tests, cognitive, nutri-
tional, and medical assessment. Baseline questionnaire
data were collected between April–May 2008; clinical
evaluation and biological sample collection were car-
ried out between June 2008 and July 2009. In the ori-
ginal cohort, a sample of 1294 participants was
calculated to ensure a sample size which could esti-
mate a prevalence of ~ 14% of frailty with α = 0.05
and β = 0.20. Among contacted potential participants,
acceptance rate was 86.9% and a total of 1124 partici-
pants completed the initial interview, which included
individuals with and without T2D. For the present
study, we included participants with T2D without
previous clinical diagnosis of dementia, defined as
self-report of previously diagnosed T2D and/or self-
report of taking T2D medications (n = 236). To ac-
count for subjects who were not previously diagnosed
with T2D, we included subjects with fasting glucose
≥126 mg/dL (n = 21), who had enough information for
their dementia-risk stratification using the DSDRS
(overall, n = 257).
Definitions for potential correlates with DSDRS
Frailty
We used a modified definition of the one proposed by
Fried et al. which was previously validated for this popu-
lation [13, 14]. This modified definition uses data from
questionnaires and self-report to define the following
dominions, previously described as: a) Unintentional
weight loss ≥5 kg in the last 12 months, b) Exhaustion, c)
Low physical activity, d) Slowness, and e) Weakness.
Participants were categorized as frail if they fulfilled ≥3
criteria, pre-frail if they fulfilled 1–2 criteria, and non-
frail if none.
Depressive symptoms
The presence of depressive symptoms was defined as a
score > 5 in the 15-item version of the Geriatric Depres-
sion Scale (GDS).
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Cognitive performance
Cognitive evaluation comprised an interview-based as-
sessment, which included a questionnaire-based cogni-
tive evaluation comprising Mini-Mental State
Examination (MMSE) evaluation, verbal fluency abilities
with the Isaacs Set Test (IST) where four semantic cat-
egories were successively used (cities, fruits, animals, and
colors) and the Clock-drawing test to assess visuo-
constructional abilities. Low cognitive performance was
based on a modified definition by Blaum et al., defined
as scores <25th percentile in both MMSE and the IST
semantic verbal fluency test or clock-drawing test, ad-
justed for sex, age, and schooling based on normative
cutoffs previously validated in the Coyoacán Cohort
Study to account for inter-ethnic influences on MMSE
scores which impact on the sentitivity of the test to de-
tect cognitive impairment [12, 15].
Disability
Determined using Lawton-Brody Instrumental Activities
of Daily Living (IADL) scale and Katz Index for the Ac-
tivities of Daily Living (ADL). We defined ADL or IADL
disability as having at least one impaired dominion in
the Katz scale (ADL disability) or the Lawton-Brody
scale (IADL disability) [16–18].
Risk of malnutrition
Assessed by the Mini-Nutritional Assessment (MNA)
questionnaire, scores < 24 were indicative of at-risk of
malnutrition.
QoL
Assessed using the self-administered generic instrument
SF-36 health questionnaire in the translated and vali-
dated version for Mexican population. Items are formu-
lated as statements to evaluate eight specific health
scales including physical functioning, physical pain, role
limitations due to physical health problems, role limita-
tions due to personal or emotional problems, emotional
well-being, social functioning, energy/fatigue and general
health perceptions. Scales were classified in two physical
(PCS) and mental component scores (MCS).
Dementia risk calculation
We evaluated dementia risk using the DSDRS [6]. Self-
reported variables included in the score considered dur-
ation of T2D from diagnosis in years, self-report of dia-
betic kidney disease (DKD) and diabetic retinopathy,
history of insulin use or oral T2D treatment, previous
diagnosis of diabetic foot or peripheral vascular disease,
acute myocardial infarction, and stroke. Microvascular
complications to estimate DSDRS considered the clus-
tering of DKD, and/or diabetic retinopathy; this defin-
ition was also used in linear and logistic regression
models. Acute metabolic event was defined as a previous
episode of hyperglycemia which required hospitalization
or hypoglycemia, defined by self-reported episodes of
hyperglycemia or fasting glucose levels < 70 mg/dL as
recommended by ADA guidelines. High dementia-risk
was defined as an estimated 10-year dementia risk >75th
age-specific percentile based on incremental 5-year age
categories described by the DSDRS. The selection of this
age-specific percentile cut-off was performed to provide
fair comparisons of DSDRS to detect age-related pheno-
types without a significant influence from age as consid-
ered in the DSDRS, whilst still allowing a detection of
high-risk individuals within each age group.
Anthropometric and biochemical evaluation
We calculated the body mass index using anthropomet-
ric evaluation using the formula of weight in kilograms
divided by height in m2. Blood samples were acquired
after a 10–12 h fast to measure fasting glucose (Yellow
Springs Instruments Co.); serum lipid concentrations
assessed total cholesterol, triglycerides and HDL-C and
were measured using colorimetric assays (Unicel DxC
600 Synchron Clinical System Beckman Coulter).
Statistical analysis
Intergroup differences
We compared groups according to the 75th age-adjusted
percentile of DSDRS using Student’s t-test or Mann-
Whitney U according to variable distribution. In all de-
scriptive analyses, distribution of categorical variables is
reported as frequencies which were compared between
groups using chi-squared tests. A p-value < 0.05 was
established as statistically significant.
Correlation between DSDRS, cognitive tests, frailty, and
disability components
To investigate the association between dementia risk
and the evaluated scores, we tested the correlation of
DSDRS with the continuous MMSE, the IST, CDT,
MNA, SF-36, Lawton, and Katz scores as well as the
number of frailty components using Spearman’s correl-
ation; 95% confidence intervals were estimated using
1000 bootstrap samples. To develop an explanatory
model for DSDRS and identify independent predictors
for dementia risk using these scores, we used step-wise
multiple linear regression analyses adjusted for sex, years
of schooling and years since diabetes diagnosis, with
model selection carried out using Bayesian Information
Criterion (BIC) minimization.
Logistic regression analyses
We developed an explanatory model for high-estimated
10-year dementia-risk to investigate the relation of sub-
jects at higher risk with the investigated clinical
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phenotypes identified by the scores when transformed
into categorical variables. For this purpose, we used lo-
gistic regression, treating high-dementia risk as the
dependent variable and including as predictors frailty,
ADL and IADL disability, risk of malnutrition and low
cognitive performance; multiple logistic regression was
carried out using step-wise models adjusted for years
since diabetes diagnosis, years of schooling and sex.
Model diagnostics were conducted using R2 and the
Hosmer-Lemeshow test. Finally, we constructed ROC
curves to estimate performance of DSDRS to identify
phenotypes of frailty, low cognitive performance, ADL
and IADL disability using probability estimates from re-
gression modes; we also calculated sensitivity and speci-
ficity for each phenotype.
Contribution of DSDRS components to the observed
associations
To investigate whether the association of DSDRS with
cognition, disability, frailty and impaired QoL were
driven by factors other than age, we fitted multiple linear
regression models to evaluate which components of the
DSDRS were primarily associated with the outcomes.
Predictors included individual components of the DSDR
S, including age, microvascular complications, depres-
sion, diabetic foot, acute metabolic events, cardiovascu-
lar and cerebrovascular disease. We included as
dependent variables scores correlated to DSDRS, which
included the frailty score, Lawton, Katz, MMSE, MNA
and SF-36 PCS. Model diagnostics were conducted using
R2 and BIC; multicollinearity was assessed using toler-
ance and variance inflation factor (VIF). Predictors were
tested on homoscedasticity and linearity assumptions;
model diagnostics were conducted evaluating normality
of residuals. Model parameters are expressed using β-
coefficients and 95%CI. All statistical analyses were per-
formed using the SPSS software (Version 22.0), R (Ver-
sion 3.6.1) and GraphPad Prism (Version 6.0).
Results
Study subjects
We included 257 subjects with T2D, with a slight female
predominance (54.1%), an average age of 78.0 ± 6.2 years
and a median of 10 years since T2D diagnosis. Insulin
use was observed in 58 subjects (22.6%), 89 subjects had
fasting glucose ≤130 mg/dL (34.6%), 89 subjects were
categorized as pre-frail (34.6%) and 32 subjects as frail
(12.5%). In relation to microvascular complications, 62
subjects referred having a previous diagnosis of diabetic
kidney disease (DKD) and 102 referred diabetic retinop-
athy (39.7%). Furthermore, 88 subjects (34.2%) referred
having any degree of diabetic foot disease; acute meta-
bolic events occurred in 19 subjects (7.4%) of whom 7
were categorized ad hypoglycemic events (2.7%) and 12
as hyperglycemic events requiring hospitalization (4.7%,
Table 1). The median of the DSDRS was 8.0 (range 6.0–
10.0), which corresponds to an estimated 10-year de-
mentia risk of 50% (40.0–63.0%), which was unevenly
distributed by sex, without significant differences in sex
distribution across dementia risk categories (p = 0.327,
Fig. 1). When assessing sex-specific differences in DSDR
S components, we identified that female participants had
less years of education (6.0 [2.0–11.0], P = 0.003) and
higher but non-significant rates of microvascular com-
plications (55.4% vs 43.2%, P = 0.051) and of diabetic
foot (39.6% vs. 28.0%, p = 0.051) compared to men but
significantly lower rates of acute metabolic events (3.6
vs. 11.9%, p = 0.012).
DSDRS, cognition, frailty, QoL and functional scores
We observed negative adjusted and unadjusted linear as-
sociations between DSDRS and MMSE, IST, SF-36 PCS,
SF-36 MCS and MNA. We also observed a positive and
significant linear associations between DSDRS and CDT,
Katz, Lawton and the frailty score (Table 2). We did not
observe a significant correlation between DSDRS, fasting
glucose, triglycerides, HDL-C, total cholesterol or BMI.
Using step-wise linear regression analyses we identified
that frailty (β = 0.400, 95%CI 0.080–0.719), MMSE (β =
− 0.153 95%CI -0.255 - -0.050) and MNA scores (β = −
0.160 95%CI -0.283 - -0.037) explained 26.8% of the vari-
ability in DSDRS, adjusted for sex, years of schooling
and years since T2D diagnosis (R2 = 0.268, p < 0.001).
Furthermore, we observed significantly higher DSDRS
among frail participants compared with non-frail sub-
jects and in subjects with disability (Fig. 2).
DRDS, decreased cognitive performance, frailty, and
disability
Subjects with high 10-year dementia risk had less years
of education, lower MNA, SF-36 PCS, SF-36 MCS,
MMSE, IST, Katz and Lawton-Brody scores, higher
frailty and GDS scores, and years of T2D exposure in
comparison to DSDRS <75th age-specific percentile
(Table 1). As expected, subjects with high 10-year de-
mentia risk were also more likely to be frail, at risk of
malnutrition (50.0% vs. 20.0%, p < 0.001), with disability
(ADL 29.8% vs. 12.4%, p = 0.002; IADL 22.0% vs. 7.1%,
p = 0.001) and a trend towards low cognitive perform-
ance (20.0% vs. 8.8%, p = 0.057). When evaluating the
role of the DSDRS score to identify frailty and disability
we observed highest area under the curve (AUC) for de-
tection of ADL disability (AUC 0.803 95%CI 0.715–
0.892; sensitivity 85.7%, specificity 61.3%), IADL disabil-
ity (AUC 0.733 95%CI 0.629–0.838; sensitivity 62.0%,
specificity 75.7%), low cognitive performance (AUC
0.704 95%CI 0.582–0.826; sensitivity 83.3%, specificity
54.3%), and frailty (AUC 0.700 95%CI 0.601–0.799;
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sensitivity 71.9%, specificity 69.1%). Using logistic regres-
sion, high-estimated 10-year dementia risk was associ-
ated to ADL and IADL disability, frailty and risk of
malnutrition, adjusted for sex, years of schooling and
years since T2D diagnosis. In multivariable logistic re-
gression analyses, frailty and risk of malnutrition were
associated with high-estimated 10-year dementia risk,
adjusted for sex, years of schooling and years since T2D
diagnosis (R2 = 0.294, χ2 =8.682, p = 0.370, Table 3).
Specific DSDRS components and outcomes
In the case of the frailty score, age, microvascular com-
plications, diabetic foot, stroke and depression explain
the observed associations. Older age, microvascular
complications and cardiovascular disease were associated
with Lawton scores whilst older age, microvascular com-
plications and were associated with lower Katz scores.
For MMSE we observed significant associations with
age, schooling, depression and microvascular
Table 1 General characteristics of subjects included in the study, as well as a comparison between individuals with DSDRS above
and below the 75th age-specific percentile, defined as high 10-year dementia risk. Results are presented as either mean ± SD or
Median (IQR), according to variable distributions. *p < 0.05
Parameter Overall sample (N = 257)
Mean ± SD/Median (IQR)
DSDRS ≤ 75th percentile (N = 198)
Mean ± SD or Median (IQR)
DSDRS > 75th percentile (N = 59)
Mean ± SD or Median (IQR)
Female sex (%) 139 (54.1) 110 (55.6) 29 (49.2)
Age (years) 78.05 ± 6.16 77.83 ± 6.14 78.79 ± 6.22
Years since T2D
diagnosis
10.0 (3.0–20.0) 7.5 (2.0–19.0) 17.0 (10.0–23.0)*
Age at T2D
diagnosis
64.93 ± 12.56 66.12 ± 12.30 61.01 ± 12.71*
Schooling (years) 6.0 (1.0–9.0) 6.0 (2.0–9.0) 3.0 (0.0–6.0)*
Glucose (mg/dL) 143.86 ± 60.23 139.13 ± 44.58 158.89 ± 93.22
Triglycerides (mg/dL) 185.36 ± 97.09 181.33 ± 97.55 198.15 ± 95.55
HDL-C (mg/dL) 42.05 ± 12.64 42.08 ± 12.97 41.98 ± 11.64
Total Cholesterol
(mg/dL)
194.52 ± 42.01 195.12 ± 42.59 192.61 ± 40.50
BMI (kg/m2) 26.99 ± 4.02 27.01 ± 3.95 26.92 ± 4.28
MMSE score 20.83 ± 5.45 21.81 ± 4.88 17.46 ± 5.99*
Isaac’s set test score 23.78 ± 6.87 24.75 ± 6.41 21.58 ± 7.43*
Clock Drawing Test 2.0 (1.0–5.0) 6.0 (2.0–9.0) 7.5 (2.0–19.0)
Geriatric depression
scale
2.0 (1.0–4.0) 2.0 (1.0–3.0) 5.0 (3.5–7.0)*
Katz scale 5.21 ± 1.41 5.44 ± 1.16 4.42 ± 1.83*
Lawton scale 5.30 ± 1.28 5.44 ± 1.11 4.83 ± 1.66*
Mini-Nutritional
Assessment
24.92 ± 3.29 25.67 ± 2.59 22.53 ± 4.12*
SF-36 PCS 43.53 ± 9.67 44.35 ± 9.71 39.87 ± 8.68*
SF-36 MCS 52.64 ± 9.59 53.66 ± 8.94 48.07 ± 11.10*
Frailty (%) 32 (15.0) 20 (11.5) 12 (30.8)*
Insulin use (%) 58 (22.6) 46 (23.2) 12 (20.3)
Stroke (%) 20 (7.8) 4 (2.0) 16 (27.1)*
Myocardial infarction
(%)
27 (10.5) 14 (7.1) 13 (22.0)*
Acute metabolic
events (%)
19 (7.4) 7 (3.5) 12 (20.3)*
Microvascular
complications (%)
128 (49.8) 73 (36.9) 55 (93.2)*
Diabetic foot (%) 88 (34.2) 52 (26.3) 36 (61.0)*
DSDRS 8.0 (6.0–10.0) 7.0 (6.0–9.0) 11.0 (9.00–12.0)*
Abbreviations: T2D Type 2 diabetes, DSDRS Diabetes-specific dementia risk score, HDL-C High-density lipoprotein cholesterol, BMI Body-mass index, MMSE Mini-
mental state examination, ADL Activities of daily life, IADL Instrumented activities of daily life
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complications, whilst for MNA scores, we observed asso-
ciations with diabetic foot disease, cardiovascular dis-
ease, stroke and depression. Finally, lower SF-36 PC
scores were associated with microvascular disease, car-
diovascular disease and depression (Supplementary
Material).
Discussion
Here, we demonstrate that the DSDRS is associated with
measures of cognitive performance, frailty, risk of mal-
nutrition, QoL, and ADL/IADL disability among
community-dwelling older adults with T2D. Further-
more, we observed higher DSDRS in pre-frail and frail
participants and among those with disability. Relying on
these associations, the identified cross-sectional pheno-
type observed using the DSDRS is consistent with what
would be expected for patients at higher risk of demen-
tia, regardless of T2D status. Subjects at higher risk of
dementia identified by the DSDRS would most likely be
frail, have some degree of disability, decreased cognitive
performance, risk of malnutrition and lower QoL. These
findings strengthen the notion that T2D and T2D-
related complications have significant burden on func-
tional status, QoL, disability and, subsequently, on de-
mentia risk.
Frailty and dementia risk by DSDRS
Older adults with T2D are at an increased risk of frailty;
furthermore, interactions between frailty and
hypoglycemia during T2D treatment have been reported
to increase dementia-risk. This is significant, since pa-
tients with increasing number of macro and
Fig. 1 Frequency distribution of estimated 10-year dementia risk amongst Mexican community-dwelling elderly with type 2 diabetes mellitus,
stratified by sex. Despite the uneven distribution, we observed no significant differences in sex across dementia risk scores
Table 2 Partial correlation analyses and multiple linear regression of DSDRS with evaluated scores in the sample, adjusted for sex,
years of schooling and years since diabetes diagnosis
Parameter Unadjusted correlation (95%CI) Adjusted correlation (95%CI) Multiple Linear R2
MMSE score −0.412 (−0.511 - -0.293) −0.359 (−0.445 - -0.277) 0.329
IST score −0.319 (− 0.470 - -0.161) − 0.250 (− 0.421 - -0.111) 0.158
Clock Drawing Test 0.285 (0.114–0.454) 0.257 (0.077–0.434) 0.170
SF-36 PCS −0.363 (− 0.482 - -0.254) −0.233 (− 0.361 - -0.117) 0.146
SF-36 MCS −0.176 (− 0.323 - -0.036) −0.183 (− 0.319 - -0.082) 0.067
Mini-nutritional assessment −0.354 (− 0.492 - -0.194) −0.326 (− 0.457 - -0.168) 0.240
Katz score −0.340 (− 0.446 - -0.226) −0.269 (− 0.370 - -0.167) 0.152
Lawton score −0.217 (− 0.342 - -0.078) −0.314 (− 0.430 - -0.173) 0.136
Frailty components 0.399 (0.282–0.509) 0.263 (0.077–0.428) 0.191
Abbreviations: DSDRS Diabetes-specific dementia risk score, MMSE Mini-mental state examination, IST Isaac’s Set Test, MNA Mini-nutritional assessment, SF-36 MCS
Mental Component Score of the SF-36 quality of life questionnaire, SF-36 PCS Physical Component Score of the SF-36 quality of life questionnaire
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microvascular complications might be assessed as re-
quiring more intensive glycemic control which, in sub-
jects with impaired functional status and frailty might
increase dementia risk [19]. The role of frailty in increas-
ing morbidity and impacting QoL in patients with T2D
has previously been shown and has led to recommenda-
tions against intensive glycemic control in this popula-
tion [20, 21]; in addition, frailty is related to vascular
damage and might contribute to increased risk of vascu-
lar dementia in T2D [22]. DSDRS might prove useful to
identify patients with impaired functional status, mul-
tiple comorbidities, and frailty, who might benefit from
less intensive T2D treatment and might require treat-
ment adjustments [21]. In our study, we did not assess
hypoglycemic episodes or hypoglycemia risk, but the
interaction between frailty and hypoglycemia in relation
to DSDRS and its impact on dementia risk should be
evaluated in future studies.
Microvascular complications and dementia risk by DSDRS
Microvascular complications, particularly diabetic retin-
opathy, are evaluated by DSDRS to discriminate subjects
with increased dementia risk who might also have dis-
ability, impaired QoL and functional status [23]. Diabetic
retinopathy and neuropathy cause severe sensory impair-
ments in older patients with T2D; furthermore, T2D has
been associated to increased risk of bilateral sensori-
neural hearing loss in addition to established micro-
vascular damage, which might contribute to further
sensory loss [24, 25]. Sensory impairments, particularly
in eyesight, hearing, and neuropathy have been associ-
ated with increased dementia risk and favor the
Fig. 2 Correlation between increasing DSDRS and MMSE a, IST b and Clock test scores c. We also show comparisons of DSDRS according to
frailty categories d, and functional status regarding activities of daily life e and instrumented activities of daily life f, demonstrating the role of
DSDRS to discriminate functional and cognitive status. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Abbreviations: DSDRS, Diabetes-specific
dementia risk score; MMSE, Mini-mental state examination; IST, Isaac’s set-test; ADL, Activities of daily life; IADL, Instrumented activities of daily life
Table 3 Simple and multiple logistic regression analyses of the association of evaluated scores and phenotypes with high-estimated
dementia risk, defined as DSDRS >75th age-specific percentiles. Analyses were adjusted for sex, years of schooling and years since
diabetes diagnosis
Model diagnostics Parameter OR (95%CI) p-value
Simple R2 = 0.108; χ2 =9.418, p = 0.308 IADL disability 2.92 (1.25–6.85) 0.014
R2 = 0.214; χ2 =3.113, p = 0.927 ADL disability 2.52 (1.15–5.51) 0.021
R2 = 0.063; χ2 =22.772, p = 0.004 Low cognitive performance 2.61 (0.94–7.20)) 0.064
R2 = 0.240; χ2 =4.254, p = 0.834 Frailty 3.91 (1.51–10.12) 0.005
R2 = 0.249; χ2 =7.161, p = 0.519 Risk of malnutrition 3.35 (1.39–8.09) 0.007
Multiple R2 = 0.294; χ2 =8.682, p = 0.370 Frailty 4.31 (1.34–13.94) 0.049
Risk of malnutrition 2.56 (1.01–6.54) 0.015
Abbreviations: DSDRS Diabetes-specific dementia risk score, MMSE Mini-mental state examination, ADL Activities of daily life, IADL impaired activities of daily life
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development of disability and increased mortality; in
addition, end-organ microvascular damage in T2D in-
creases risk of falls and impairment of functional status
[26, 27]. The role of microvascular damage in the patho-
physiology of dementia in diabetes has also been studied,
but the evidence of this association is inconsistent and
neurological changes have been observed in individuals
with T2D without end-organ microvascular damage
[28]. Thus, DSDRS might identify individuals at high risk
of disability in IADL and ADL due in part to sensory im-
pairment by recognizing a population with increased de-
mentia risk in whom rehabilitation would be beneficial
[29]. The role of depression, macro and microvascular
factors and obesity in promoting disability in individuals
with T2D has also been reported, and its evaluation by
the score contributes to the identification of individuals
with ADL and IADL disability [30].
Cognition, microvascular complications and DSDRS
Older adults with T2D present lower performance on
cognitive evaluations, particularly when affected by mi-
cro and macrovascular complications [31]. Cognitive
evaluations of individuals with T2D have demonstrated
impaired domains in information processing speed,
visuospatial functions, attention, executive functioning
abstract reasoning [32]; furthermore, individuals with
T2D present a higher rate of cognitive decline, directly
dependent with glycemic control. Individuals with T2D
and cognitive impairment also experience a higher rate
of conversion to dementia, with earlier disease onset and
increased disease progression in relation to T2D dur-
ation and microvascular complications, as has been
shown in previous studies [33, 34]. The lower cognitive
performance observed in individuals with increased
DSDRS in our study might be attributable to the consid-
eration of microvascular damage, age and glycemic con-
trol, which underlie associations with impaired cognition
in T2D in most prospective studies. Furthermore, the
impact of frailty and disability on cognition, both of
which increase dementia risk, must also be considered
[35, 36]. Since individuals with T2D are a population
with high susceptibility to impaired cognition, our dem-
onstration of lower cognitive performance when screen-
ing subjects using the DSDRS provides evidence for its
utility in a cross-sectional setting. Future longitudinal
studies should shed light on the role of DSDRS for pre-
diction of cognitive impairment conversion to dementia
in individuals with T2D.
Strengths and limitations
Our study had some strengths and limitations. First, we
performed a wide range of evaluations, which allowed a
thorough assessment of cognition, QoL, disability, and
frailty in a sample of community-dwelling individuals
with T2D in which most of these predictors had previ-
ously been validated. We also demonstrated that the
DSDRS identifies subjects who could be considered for
short-term interventions to improve function and ameli-
orate the negative effects of disability, frailty and T2D
related complications. Furthermore, this is the first study
in which DSDRS is used besides its original evaluation,
demonstrating its utility in different populations and set-
tings. Validation of DSDRS for functional and frailty sta-
tus as demonstrated in this study allows to characterize
the phenotype observed for subjects with high-estimated
dementia risk score and extend the applications of
DSDRS; nevertheless, prospective validation studies are
required to both externally validate the score in different
populations and replicate the observed associations for
DSDRS in this study.
Amongst the limitations to be acknowledged is its
cross-sectional setting, which limits the ability to es-
tablish causal relationships and the self-report of co-
morbidities and T2D complications, which might
underestimate the true impact of the associations.
The modified frailty definition which uses self-
reported measures instead of physical evaluations has
previously been applied in other studies involving
the Coyoacán Cohort study; furthermore, epidemio-
logical studies in other settings with self-reported
data have been conducted and yielded reproducible
results [17, 37]. Recent studies have compared the
performance of frailty definitions which substitute
physical based for self-reported based measures,
identifying adequate diagnostic performance for self-
reported definitions and adequate concordance with
physical based definitions [38, 39]. Given this evi-
dence, we propose that this operational definition
should adequately capture the variability of the
frailty phenotype in our subjects. Since the evaluated
sample was representative of the community and
previous reports have shown an increased rate of un-
diagnosed T2D in our population [1], some cases of
T2D with fasting glucose < 126 mg/dL could have
been excluded, thus limiting information of such
cases. In addition, since no specific dementia infor-
mation was available for diagnosis in the Coyoacán
Cohort study there exists a possibility for undiag-
nosed cases of dementia not identified by cognitive
assessment, thus modifying the strength of these as-
sociations. Our results however are in accordance
with recent findings which show that DSDRS might
be useful to detect cognitive impairment in indivu-
dals with T2D [40]. Moreover, cognitive assessment
did not include more extensive measures of execu-
tive function, which are highly sensitive to T2D-
related cognitive changes and remain to be explored
in future studies.
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Conclusions
The DSDRS is associated with frailty, disability, risk of
malnutrition, lower cognitive performance and impaired
quality of life. Evaluation of this score in primary care fa-
cilities might prove useful for identification of subjects
with T2D who might benefit from multidisciplinary in-
terventions focusing on rehabilitation to improve upon
IADL and ADL disability, frequent cognitive screening,
nutritional counseling and evaluation of interventions to
reduce burden related to frailty. The role of said inter-
ventions to delay onset of cognitive decline and demen-
tia in high risk patients identified using the DSDRS
should be evaluated in future studies.
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